Alzheimer's-associated psychosis
Phase III · ADEPT-5
A randomised, double-blind, placebo-controlled study of an investigational treatment (KarXT + KarX-EC) for psychosis symptoms in people living with Alzheimer's disease.
View on ClinicalTrials.gov ↗ Register interest